Search results
Common low-calorie sweetener linked to heart attack and stroke, study finds
CNN via Yahoo News· 2 days agoA common low-calorie sweetener called xylitol, found in gum, candy, toothpaste and more, may cause...
Xylitol sugar substitute linked to increased risk of heart attack and stroke, study finds
CBS News· 2 days agoXylitol is the latest sugar substitute to be linked to potential negative health impacts. In a study...
New Study Finds That This Common Low-Calorie Sweetener Could Increase Your Risk of a Heart Attack or...
First for Women via Yahoo News· 2 days ago“It’s sold as a so-called natural sweetener, and because xylitol doesn’t spike blood sugar levels,...
Xylitol Increases Heart-Health Risks
Time via Yahoo News· 2 days agoHazen says xylitol should be considered similar to cholesterol...it's made in the body, and people have varying levels of the chemical in their blood....
Artificial Sugar Xylitol and Heart Attack Risk: What to Know
Healthline· 1 day agoA new report, published on June 6, suggests xylitol might impair the body’s clotting abilities....
Women May Have Heart Risks at Lower Blood Pressures Than Men
Scientific American· 2 days ago“There’s not enough evidence to say, ‘Yes, women should be treated for hypertension at a lower blood...
Researchers find GLP-1 medications safe to continue before surgery in patients with diabetes and...
Medical Xpress· 4 days agoAs more patients begin taking medications to help manage blood sugar levels and weight loss, concerns about whether these medications are safe to take prior ...
Expert: If You're a Senior, Watch Out for These 7 Common Mental Health Issues
Cheapism via AOL· 2 days agoThere is the mistaken belief that seniors are less active, so they require less sleep. But during...
Unlocking Sweet Secrets: How Taste Perception Influences Glucose Metabolism
SciTechDaily· 5 days agoResearch identifies new potential areas for managing metabolic disorders, such as diabetes. The rich...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 5 hours agoEli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or without type 2 diabetes, to evaluate the investigational ...
